News

A Washington University in St. Louis drug discovery program has received three grants totaling more than $5 million from the National Institutes of Health (NIH) to develop new therapeutics for respiratory diseases. The target illnesses range from the common cold to life-threatening lung disease.
| 3 min read

Patent grants in US as Elasmogen moves closer to commercialization and clinical development.
| 3 min read

Using the same baking soda found in most grocery stores, Lawrence Livermore National Laboratory scientists, along with colleagues from Harvard University and the University of Illinois at Urbana-Champaign, have created a significant advance in carbon dioxide capture.
| 3 min read

















